Quantification of PET activation in adipose tissue from non-contrast CT scans - Scorecard - MDSpire

Quantification of PET activation in adipose tissue from non-contrast CT scans

  • By

  • Carlos Cano-Espinosa

  • Michael W. Subrize

  • Elisa Franquet

  • Aaron M. Cypess

  • Gerald Kolodny

  • George R. Washko

  • Raúl San José Estépar

  • February 5, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Adipose Tissue PET Activation Using Non-Contrast CT Imaging Techniques

At a Glance

CategoryDetail
ConditionBrown adipose tissue (BAT) metabolic activity assessment
Key MechanismsDeep learning model (conditional GAN) predicts PET-like standardized uptake values (SUV) from non-contrast CT scans to estimate regional adipose tissue metabolic activity
Target PopulationAdults undergoing chest CT scans, including populations at risk for metabolic and cardiometabolic diseases
Care SettingClinical and research imaging settings utilizing routine non-contrast chest CT without additional radiotracer imaging

Key Highlights

  • Brown adipose tissue plays a key role in energy metabolism and cardiometabolic health.
  • Standard 18F-FDG PET imaging for BAT is costly, radiation-intensive, and impractical for large-scale screening.
  • A deep learning model enables radiation-sparing, PET-like assessment of adipose tissue metabolic activity from routine non-contrast CT scans.

Guideline-Based Recommendations

Diagnosis

  • Use paired PET/CT data to train and validate deep learning models for estimating BAT activity from CT.
  • Identify adipose tissue regions on non-contrast CT to serve as input for metabolic activity prediction.

Management

  • Implement deep learning-based CT analysis as a non-invasive, radiation-sparing alternative to PET for assessing BAT activity.
  • Utilize this method to support population-based studies and clinical evaluation of metabolic health without additional imaging burden.

Monitoring & Follow-up

  • Apply reproducible CT-based metabolic activity predictions across anatomical regions and datasets for longitudinal monitoring.
  • Incorporate routine chest CT scans to track BAT activity changes over time in clinical and research contexts.

Risks

  • Consider limitations related to model generalizability and institutional data access policies.
  • Acknowledge that this method does not replace PET but offers a complementary, less invasive assessment.

Patient & Prescribing Data

Patients undergoing chest CT imaging, including those with metabolic or cardiometabolic risk factors

Non-contrast CT combined with deep learning can estimate BAT metabolic activity, potentially guiding metabolic health assessment without additional radiation or tracer exposure.

Clinical Best Practices

  • Leverage paired PET/CT datasets for model training to ensure accurate metabolic activity prediction from CT.
  • Incorporate fat-focused loss functions in deep learning models to enhance metabolic signal estimation.
  • Use publicly available datasets and open-source code to facilitate reproducibility and broader clinical adoption.
  • Adhere to ethical guidelines and institutional approvals when utilizing imaging data for research.

References

Original Source(s)

Related Content